Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar;184(3):385.
doi: 10.1111/bjd.19434. Epub 2020 Sep 2.

Better reporting of safety data in clinical trials of biologic drugs in psoriasis is still needed

P Dávila-Seijo  1
Affiliations
Comment

Better reporting of safety data in clinical trials of biologic drugs in psoriasis is still needed

P Dávila-Seijo. Br J Dermatol. 2021 Mar.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Afach S, Chaimani A, Evrenoglou T et al. Meta-analysis results do not reflect the real safety of biologics in psoriasis. Br J Dermatol 2021; 184:415-24.
    1. Singh JA, Wells GA, Christensen R et al. Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev 2011; 2011:CD008794.
    1. Sbidian E, Chaimani A, Afach S et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev 2020; 1:CD011535.
    1. Garcia-Doval I, Carretero G, Vanaclocha F et al. Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible versus eligible for randomized controlled trials. Arch Dermatol 2012; 148:463-70.
    1. Ormerod AD, Augustin M, Baker C et al. Challenges for synthesising data in a network of registries for systemic psoriasis therapies. Dermatology 2012; 224:236-43.